RXD

ProShares UltraShort Health Care
*Unless otherwise stated, data provided by FactSet.

RXD Fund Description

RXD provides -2x exposure to a market-cap-weighted index of US financial services companies.

RXD Factset Analytics Insight

RXD provides daily geared inverse (-2x) exposure to the Dow Jones US Health Care Index. It charges 95 bps for holding swaps on the index and the iShares US Healthcare ETF (IYH). The index has about a 65% stake in the pharmaceuticals alone, making RXD, in essence, a leveraged bet against the pharmaceutical industry. RXD has next to nothing in AUM and carries a high fund-closure risk. It has nonexisting liquidity, with low daily trading volume and wide spreads, making RXD a very poor and expensive trading vehicle. Considering RXD is a tactical tool, the onerous costs of trading undermine the product’s usefulness. Due to daily compounding, it’s unlikely to achieve its stated exposure and returns for longer than a 1-day period.

RXD Charts And Performance

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

RXD Summary Data

ProShares
01/30/07
Open-Ended Fund
0.95%
$2.42M
0.49%

RXD Portfolio Data

1.11%
09/23/20

RXD Index Data

Market Cap
Market Cap
N/A

RXD Fund Structure

Yes
No
No Policy
N/A
N/A
High
-2
Daily

RXD Tax Exposures

20.00% / 39.60%
--
No
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

RXD Factset Analytics Block Liquidity

As of 07/03/20
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of RXD. RXD is rated a N/A out of 5.

RXD Tradability

8,064
$110.78K
6,417
$89.11K
0.49%
$0.06
0.02%
1.80% / -4.92%
None
0.00%
25,000
0.26
0.08%
--
0
$13.23
N/A